Company Profile
Hims & Hers Stock Price, News & Analysis
- Ticker:
- HIMS
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
32.74 USD (+3.35%)
Close
Last updated: July 23, 2026
6.37B USD
Market cap
Why the stock is moving
HIMS is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Hims & Hers is a consumer telehealth company delivering direct-to-consumer care across hair loss, mental health, sexual health, and other self-pay categories.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Hims sits in digital health and consumer services.
Business Model Characteristics
The business depends on subscription economics, branded consumer demand, and the ability to expand across adjacent self-pay healthcare categories.
Position Within the Biotechnology Landscape
Hims is not a biotech name, but it is a fast-growing healthcare platform whose stock reacts to customer growth and monetization.
Future catalysts
Hims & Hers's catalysts are membership growth, weight-loss and primary-care expansion, and whether the platform can keep monetizing its direct-to-consumer health base. The company matters most when new categories turn into recurring subscribers rather than one-time spikes.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast
BRKR · Source: Bruker
- 02
Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026
DGX · Source: Quest Diagnostics
- 03
Molina Healthcare Reports Second Quarter 2026 Financial Results
MOH · Source: Molina Healthcare
- 04
Axon to Release Second Quarter 2026 Earnings on August 5, 2026
AXON · Source: Axon Enterprise, Inc.
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Hims & Hers (HIMS)?
Hims & Hers (HIMS) most recently closed at 32.74 USD, a +3.35% move versus the previous session.
What is the market cap of Hims & Hers (HIMS)?
Hims & Hers currently has a market capitalization of 6.37B USD on BioPharmSignal.
What does Hims & Hers do?
Hims & Hers is a consumer telehealth company delivering direct-to-consumer care across hair loss, mental health, sexual health, and other self-pay categories.
On which exchange is HIMS stock listed?
Hims & Hers (HIMS) is associated with NYSE, United States, Biopharma.
What is Hims?
Hims & Hers's catalysts are membership growth, weight-loss and primary-care expansion, and whether the platform can keep monetizing its direct-to-consumer health base.
Which conditions is Hims & Hers targeting with Hims?
Hims & Hers's catalysts are membership growth, weight-loss and primary-care expansion, and whether the platform can keep monetizing its direct-to-consumer health base.
How does Hims & Hers describe recent progress with Hims?
Hims & Hers's catalysts are membership growth, weight-loss and primary-care expansion, and whether the platform can keep monetizing its direct-to-consumer health base.
What is Hers?
Hims & Hers is a consumer telehealth company delivering direct-to-consumer care across hair loss, mental health, sexual health, and other self-pay categories.